India · Advertising framework
Paid social campaigns for OTC medicines in India
General market orientation, not campaign clearance. Research scope and dates
Product and service rules
Check prohibited drug claims rather than importing another country’s Rx rule
Legal requirement — paraphrased
The Drugs and Magic Remedies Act prohibits advertisements for specified purposes and scheduled diseases or conditions, misleading drug advertisements and specified magic-remedy advertising. Check the exact claim, Schedule, product and statutory exceptions. Do not infer that non-prescription availability permits disease claims, or that India uses the same universal public-Rx rule as EU countries.
Sources: Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954
Channel rules
Check the complete consumer-facing message
Regulator guidance
CCPA guidance addresses unsubstantiated claims, exaggerated promises and misleading advertisements and endorsements. Review the complete representation and its evidence, including claims made by an endorser. Disclosure or a disclaimer is not a substitute for the substantive conditions of a lawful advertisement.
Sources: Prevention of Misleading Advertisements and Endorsements, 2022
Separate enactment from commencement
Legal requirement — paraphrased
As of 25 October 2026, do not describe the entire DPDP consent and data-fiduciary regime as operational. The Act notification commences institutional provisions on publication, section 6(9) and section 27(1)(d) after one year, and principal processing, consent, rights and duty provisions after eighteen months.
Rules 1, 2 and 17–21 commence on publication; rule 4 after one year; rules 3, 5–16, 22 and 23 after eighteen months. Read these periods with the December 2025 corrigendum and record the applicable date for the campaign. Phasing does not itself remove other applicable privacy, confidentiality or telecom obligations.
Sources: DPDP Act commencement GSR 843(E); DPDP Rules 2025; DPDP Rules corrigendum December 2025
Approve each placement and targeting setup
Editorial recommendation
Review every crop, caption, carousel and boosted creator asset. Document targeting inputs and remove health-data audiences unless a separate privacy review supports them.
Campaign workflow
OTC Medicines: prepare the review
Editorial recommendation
Confirm the exact product qualifies for consumer advertising in this country. Match each indication, dosage and safety statement to the current local product information. Obtain the applicable warning wording and format rules before buying space.
Keep a traceable campaign decision
Editorial recommendation
Keep one review record linking the offer, local market status, claim evidence, exact creative, media settings and any regulatory or professional clearance. Record who checked each condition. Reopen the review when the offer, claim, source rule or execution changes.
Pre-publication checklist
- Confirm the exact product qualifies for consumer advertising in this country.
- Match each indication, dosage and safety statement to the current local product information.
- Obtain the applicable warning wording and format rules before buying space.
- Record product or provider eligibility before approving claims.
- Archive the final creative and its evidence, permissions and review decisions.
- Assign an owner for source updates, complaints and prompt withdrawal of inaccurate material.
Scope and unresolved questions
- Dental provisions and DPDP commencement phases have been added; the current NMC index points to the 2023 abeyance notification restoring the 2002 regime. State clinical establishment and pharmacy rules, AYUSH conduct, current Drugs Rules schedules and later FSSAI claim amendments remain incompletely verified. Check later Gazette amendments and actual product/registration details.
- This national baseline does not review every broadcaster rule, platform policy, regional licensing condition, promotion mechanic or data-transfer arrangement. No format-specific warning dimensions or durations should be inferred where none are supplied.
Research scope, introduction and dates
For OTC medicines in paid social campaigns in India, confirm the advertising status of the exact product. This framework connects the locally permitted uses with the information, warnings and execution checks relevant to the selected channel.
For paid social, review each placement variant as well as the caption, advertiser identity, audience setup and landing page. Boosted creator content also brings the commercial relationship and its disclosure into the assessment.
General market orientation, not legal, regulatory or medical advice, a complete compliance plan or clearance of an advertisement. Actual requirements depend on the specific offer and campaign.
How to use this national baseline
Editorial overview
This framework combines researched national rules with editorial review steps. Central advertising and health-product baseline; state licensing and profession-specific conditions need local review. A visible channel workflow does not establish that the selected product or service may be advertised there. Read the category restrictions first.
The review date identifies when the cited provisions or regulator excerpts were checked. It does not mean that every local rule, exception, professional standard or platform policy has been reviewed.
Sources
- Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- Prevention of Misleading Advertisements and Endorsements, 2022
Targeted source review; apply the cited provision to the exact offer and check subsequent changes before launch.
- DPDP Act commencement GSR 843(E)
Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.
- DPDP Rules 2025
Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.
- DPDP Rules corrigendum December 2025
Follow-up review of the cited issue on 25 October 2026; scope and remaining conditions are recorded in the modules and review register.
From framework to action
Local expertise in India
Find support with medical and health marketing, marketing and sales advice, or organizing your business and coordinating projects in India.
Medical & health marketing
No partners listed in this category yet.
Marketing & sales advisory
No partners listed in this category yet.
Business & project coordination
No partners listed in this category yet.
Join the local partner directory
Would you like your company to be listed?
Talk to us about the terms of a listing. Leave your details and we will get in touch.